Moving at the speed of pharma digitalisation: driving ROI from AI and digital tools
Source: Pharmaceutical Technology· GlobalData· August 17, 2026
SynaBot summary
Pharmaceutical companies are significantly increasing investments in AI and digital tools, projecting an 11.12 billion dollar spend by 2026. This rapid expansion aims to improve operational efficiency and drive returns on investment through advanced technologies.
Key takeaways
- Pharma AI spending to nearly triple by 2026.
- Companies seek ROI from digital transformation.
- Operational scaling challenges accompany rapid tech adoption.
- Industry leaders discuss scaling digital projects.
Why it matters
For professionals leveraging AI tools, this trend signals growing enterprise adoption and integration. Expect more sophisticated AI applications and data-driven insights emerging from industries like pharmaceuticals, potentially offering new efficiencies for your own workflows.
This story was reported by Pharmaceutical Technology. Read the full original article:
Read on Pharmaceutical Technology Try this on SynaBot
Related AI assistants, prompts, and tools from the SynaBot catalog.
AI Tools
- Digital First AIDigital First AI is an AI-powered platform designed for marketing teams to generate custom marketing plans and content ideas across various channels, helping to accelerate campaign development and execution.
- SpeedwriteSpeedwrite is an AI content generator that quickly creates new, unique text from existing content. It's ideal for generating fresh paragraphs, rewriting sentences, and avoiding plagiarism. A simple tool for fast content creation and modification.
- DigitalGeniusDigitalGenius uses deep learning to automate customer service interactions. It provides agents with suggested answers and automates repetitive tasks.
